Cholesterol-reducing drugs may lessen brain function

Feb 23, 2009

Research by an Iowa State University scientist suggests that cholesterol-reducing drugs known as statins may lessen brain function.

Yeon-Kyun Shin, a biophysics professor in the department of biochemistry, biophysics and molecular biology, says the results of his study show that drugs that inhibit the liver from making cholesterol may also keep the brain from making cholesterol, which is vital to efficient brain function.

"If you deprive cholesterol from the brain, then you directly affect the machinery that triggers the release of neurotransmitters," said Shin. "Neurotransmitters affect the data-processing and memory functions. In other words -- how smart you are and how well you remember things."

Shin's findings will be published in this month's edition of the journal Proceedings of the National Academy of Sciences of the United States of America.

Cholesterol is one of the building blocks of cells and is made in the liver. Low-density lipoprotein (LDL) -- often referred to as bad cholesterol -- is cholesterol in the bloodstream from the liver on the way to cells in the body. High-density lipoprotein (HDL) -- so-called good cholesterol -- is cholesterol being removed from cells. Too much LDL going to cells and not enough being removed can lead to cholesterol deposits and hardening of the cells.

"If you have too much cholesterol, your internal machinery is not going to be able to take away enough cholesterol from the cells," said Shin. "Then cells harden and you can get these deposits."

Cholesterol-reducing statin drugs are helpful because they keep the liver from synthesizing cholesterol so less of the substance is carried to the cells. This lowers LDL cholesterol.

It is the function of reducing the synthesis of cholesterol that Shin's study shows may also harm brain function.

"If you try to lower the cholesterol by taking medicine that is attacking the machinery of cholesterol synthesis in the liver, that medicine goes to the brain too. And then it reduces the synthesis of cholesterol which is necessary in the brain," said Shin.

In his experiments, Shin tested the activity of the neurotransmitter-release machinery from brain cells without cholesterol present and measured how well the machinery functioned. He then included cholesterol in the system and again measured the protein function. Cholesterol increased protein function by five times.

"Our study shows there is a direct link between cholesterol and the neurotransmitter release," said Shin. "And we know exactly the molecular mechanics of what happens in the cells. Cholesterol changes the shape of the protein to stimulate thinking and memory."

While reducing the cholesterol in the brain may make you have less memory and cognitive skills, more cholesterol in the blood does not make people smarter. Because cholesterol in the blood cannot get across the blood brain barrier, there is no connection to the amount of cholesterol a person eats and brain function.

Shin says that for many people taking cholesterol-lower statins can be very healthful and they should listen to their doctor when taking medication.

Source: Iowa State University

Explore further: Not just for the holidays, mistletoe could fight obesity-related liver disease

add to favorites email to friend print save as pdf

Related Stories

Washington takes on Uber with its own taxi app

7 hours ago

Washington is developing a smartphone app to enable its taxis to compete head-on with Uber and other ride-sharing services, the US capital's taxi commission said Friday.

Comet 67P/Churyumov-Gerasimenko in living color

7 hours ago

Rosetta's OSIRIS team have produced a color image of Comet 67P/Churyumov-Gerasimenko as it would be seen by the human eye. As anticipated, the comet turns out to be very grey indeed, with only slight, subtle ...

EU clean air, waste laws at risk

7 hours ago

EU Commission chief Jean-Claude Juncker faces a clash with lawmakers after leaked documents Friday revealed his plans to drop laws on clean air and waste recycling.

Recommended for you

Stem cells faulty in Duchenne muscular dystrophy

20 hours ago

Like human patients, mice with a form of Duchenne muscular dystrophy undergo progressive muscle degeneration and accumulate connective tissue as they age. Now, researchers at the Stanford University School of Medicine have ...

User comments : 1

Adjust slider to filter visible comments by rank

Display comments: newest first

deatopmg
not rated yet Feb 24, 2009
This is a VERY well known side effect of statins along w/ muscle cramping, heart failure, amnesia, plus hardly a change in overall mortality (except in 1 (one) out of hundreds of studies)

When a drug (statin) is pre-screened before a trial and over 40 percent of the people drop out due to serious side effects (see above) then, on completion of the trial itself, the scientists (ghost writers) report very high compliance - something stinks!

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.